Direct-to-Consumer (DTC) prescription drug advertising continues to be controversial. On the Friday before the Fourth of July Congressional recess, Senate Majority Leader (and noted heart surgeon),
Bill Frist (R-TN) took to the floor and called for a two- year moratorium on advertising of any newly approved DTC drug products. Senator Frist stated that this moratorium was necessary among other
reasons because "...drug advertisements are fuel to America's skyrocketing prescription drug costs." In addition, Senator Frist called for pre-approval by the Food and Drug Administration (FDA) of all
DTC advertising.
Read the whole story at ANA Blog - Dan Jaffe, August 23, 2005 »
